Tumors of the TS1 subtype were characterized by a high proportion of tumor cells, low proportions of fibroblasts and T cells, and activation of the mucin (MUC1/4/5AC) pathway, suggesting that targeting the mucin pathway in combination with chemotherapy could be effective. The gene discussed is MUC5AC; the disease is neoplasm.